ASTROTECH Corp

Astrotech Corporation announced its Board of Directors has approved a potential sale process for its 1st Detect Corporation subsidiary, developer of the TRACER 1000 mass spectrometry-based explosives and narcotics trace detection platform. The potential divestment aims to generate capital to fund Astrotech's previously announced lunar mining initiative. 1st Detect has achieved significant milestones, including TSA and ECAC certifications, entry into the TSA checkpoint certification process, and a U.S. Department of Homeland Security award, positioning its TRACER 1000 as a leading next-generation ETD platform amidst an industry shift from legacy IMS technology.

Astrotech Corporation entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC on June 2, 2026. This agreement allows Astrotech to offer and sell shares of its common stock with an aggregate offering price of up to $24,492,819. Sales will be conducted through Wainwright, who will receive a 3.0% commission on gross proceeds, though the company is not obligated to sell any shares.

Astrotech Corporation announced its Board of Directors has approved a strategic initiative focused on lunar resource development, autonomous lunar industrial infrastructure, and future Moon-based advanced computing and semiconductor manufacturing. This initiative aims to position Astrotech to evaluate emerging opportunities associated with NASA's Artemis Program and the Commercial Lunar Payload Services (CLPS) program. The company will focus on developing infrastructure for lunar silicon purification, semiconductor wafer production, AI and high-performance computing, quantum cooling, and quantum computing fabrication utilizing lunar-derived silicon-28. Astrotech believes the Moon offers unique long-term value for advanced computational infrastructure.

EN-SCAN, a subsidiary of Astrotech Corporation, announced the commercial launch of its Labrador HH-GC, a rugged, field-portable gas chromatograph. This device brings laboratory-grade volatile organic compound (VOC) analysis directly to the point of investigation, offering rapid detection at parts-per-billion sensitivity across air, water, and soil matrices. The Labrador HH-GC aims to reduce delays, uncertainty, and costs associated with traditional off-site laboratory workflows, enabling faster remediation decisions and improved operational efficiency for environmental consulting firms and industrial operators.

Astrotech Corporation reported its financial results for the third quarter of fiscal year 2026, ending March 31, 2026, with revenue of $343 thousand and a net loss of $(3,768) thousand. Despite the increased net loss and decreased revenue, the company achieved a 28% decline in research and development expenses as it transitions to saleable products. Astrotech also highlighted the deployment of its TRACER 1000 trace detection system in 37 locations across 16 countries, demonstrating progress in its product lines.

Astrotech Corporation reported a significant decline in financial results for the third quarter of fiscal year 2026, with revenue decreasing by 36% to $343 thousand and net loss increasing to $(3.77) million from $(3.63) million in the prior year. Gross profit also saw a substantial drop of 72% to $67 thousand. Despite the financial downturn, the company highlighted a 28% reduction in research and development expenses as it transitions to saleable products and noted the deployment of its TRACER 1000 system in 37 locations across 16 countries. The CEO emphasized disciplined execution, cost-efficiency, and a healthy sales pipeline.

Astrotech Corporation announced that its 1st Detect TRACER 1000 system has received ECAC/EU G1 approval, meeting the highest European standards for aviation security. This certification validates the system's ability to balance screening speed and detection certainty, providing definitive molecular identification to reduce false alarms and enhance security. The TRACER 1000 is already deployed in 16 countries and its expandable threat library helps airports adapt to evolving risks.